Cboe Global Markets
CBOE CBOE Financial Exchanges & Data Financials FY2016βFY2025
Cboe Global Markets' revenue rose 15.1% to $4.7 billion in fiscal 2025. Its operating margin was 31.1%, up from 26.8% a year earlier. Free cash flow was $1.7 billion, up 61.7%. It paid out $351 million in dividends and buybacks, 21% of free cash flow. The diluted share count fell 0.4%.
What Cboe Global Markets does
No business description yet.
- Legal name
- Cboe Global Markets, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-010013
0001374310
Revenue and margins
Cboe Global Markets had $4.7B of revenue in fiscal 2025, up 15.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 18.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.7B in fiscal 2025, 35.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cboe Global Markets returned $351M to shareholders in fiscal 2025, 21% of free cash flow. The diluted share count fell 0.4%.
Value Cboe Global Markets yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $810M and divides by 105.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 26.5x Β· peers 29.5x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Cboe Global Markets can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $379M | $524M | $601M | $1.0B | $2.3B |
| Debt incl. finance leases | $1.3B | $1.7B | $1.4B | $1.4B | $1.4B |
| Net debt / EBITDA | 1.0x | 1.9x | 0.7x | 0.3x | β0.5x |
| Debt / equity | 0.4x | 0.5x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 16.8x | 8.2x | 17.0x | 21.3x | 28.1x |
| Current ratio | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
| Quick ratio | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
| Total assets | $6.8B | $7.0B | $7.5B | $7.8B | $9.3B |
| Total liabilities | $3.2B | $3.5B | $3.5B | $3.5B | $4.2B |
| Shareholders' equity | $3.6B | $3.5B | $4.0B | $4.3B | $5.1B |
| Net debt (β = net cash) | $920M | $1.2B | $839M | $410M | β$810M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$2.3M
4 insiders
Of sales under plans
30%
$0.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Janet P FroetscherDirector | Sold plan | 937 | $278.95 | $0.3M | Form 4 |
| May 18, 2026 | Janet P FroetscherDirector | Sold plan | 1,223 | $358.09 | $0.4M | Form 4 |
| Feb 23, 2026 | Allen WilkinsonSVP, Chief Accounting Officer | Sold | 248 | $292.79 | $0.1M | Form 4 |
| Feb 18, 2026 | Alexander Matturri JRDirector | Sold | 1,500 | $285.36 | $0.4M | Form 4 |
| Feb 18, 2026 | Edward J. FitzpatrickDirector | Sold | 3,947 | $285.87 | $1.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 7 / 9 | 9 / 9 |
| Accruals ratio | β4.3% | β4.4% | β7.6% |
| Altman Z'' | 3.77 | 4.32 | 5.05 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Cboe Global Markets CBOE | $35.7B | 15.1% | 31.1% | 35.7% | 22.8% | 26.5x | 9 | |
| CME Group CME | $109.6B | 6.4% | 64.9% | 64.3% | 11.9% | 25.1x | 7 | Compare β |
| MSCI MSCI | $44.5B | 9.8% | 54.7% | 49.4% | 44.5% | 32.6x | 7 | Compare β |
| Coinbase COIN | $43.3B | 9.4% | 20.0% | 31.9% | 14.5% | β | 4 | Compare β |
| Moody's MCO | $83.8B | 8.9% | 43.4% | 33.4% | 31.1% | 29.5x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $703M | $2.2B | $2.8B | $2.5B | $3.4B | $3.5B | $4.0B | $3.8B | $4.1B | $4.7B |
| Gross profit | $566M | $996M | $1.2B | $1.1B | $1.3B | $1.5B | $1.7B | $1.9B | $2.1B | $2.4B |
| Operating income | $298M | $372M | $599M | $537M | $662M | $806M | $490M | $1.1B | $1.1B | $1.5B |
| Interest expense | $5.7M | $42.6M | $40.5M | $37.8M | $38.7M | $48.0M | $60.0M | $62.4M | $51.5M | $52.3M |
| Pretax income | $307M | $334M | $571M | $501M | $660M | $756M | $433M | $1.0B | $1.1B | $1.6B |
| Income tax | $121M | β$66.2M | $146M | $131M | $192M | $227M | $198M | $286M | $319M | $467M |
| Net income | $187M | $402M | $427M | $375M | $468M | $529M | $235M | $761M | $765M | $1.1B |
| Diluted EPS | $2.27 | $3.69 | $3.76 | $3.34 | $4.27 | $4.92 | $2.19 | $7.13 | $7.21 | $10.42 |
| Diluted shares | 0.08B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B |
| Cash flow | ||||||||||
| Cash from operations | $230M | $374M | $535M | $633M | $1.5B | $597M | $651M | $1.1B | $1.1B | $1.8B |
| Capital expenditure | $44.4M | $37.5M | $36.3M | $35.1M | $47.4M | $51.0M | $59.8M | $45.0M | $60.9M | $71.0M |
| Free cash flow | $185M | $337M | $498M | $598M | $1.4B | $546M | $591M | $1.0B | $1.0B | $1.7B |
| Depreciation and amortization | $44.4M | $192M | $204M | $177M | $159M | $167M | $167M | $158M | $133M | $122M |
| Stock-based compensation | $14.5M | $52.6M | $35.1M | $21.8M | $21.7M | $26.6M | $30.7M | $41.3M | $41.8M | $50.4M |
| Acquisitions | $14.3M | $1.4B | $0.0M | $0.0M | $352M | $152M | $708M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $60.5M | $0.0M | $141M | $157M | $349M | $81.3M | $101M | $83.9M | $205M | $66.7M |
| Dividends paid | $78.5M | $118M | $130M | $150M | $171M | $193M | $209M | $224M | $249M | $284M |
| Dividends and buybacks | $139M | $118M | $271M | $307M | $520M | $275M | $310M | $307M | $454M | $351M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $97.3M | $191M | $311M | $300M | $338M | $379M | $524M | $601M | $1.0B | $2.3B |
| Total debt | β | $1.2B | $1.2B | $868M | $1.2B | $1.3B | $1.7B | $1.4B | $1.4B | $1.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $235M | $435M | $684M | $608M | $1.6B | $1.5B | $1.6B | $2.0B | $2.5B | $4.4B |
| Current liabilities | $89.9M | $334M | $596M | $282M | $1.3B | $1.2B | $1.5B | $1.4B | $1.4B | $2.4B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $55.9M | $73.9M | $71.7M | $47.0M | $82.6M | $105M | $108M | $109M | $118M | $133M |
| Total assets | $477M | $5.3B | $5.3B | $5.1B | $6.5B | $6.8B | $7.0B | $7.5B | $7.8B | $9.3B |
| Total liabilities | $146M | $2.2B | $2.1B | $1.8B | $3.2B | $3.2B | $3.5B | $3.5B | $3.5B | $4.2B |
| Shareholders' equity | $318M | $3.1B | $3.2B | $3.4B | $3.3B | $3.6B | $3.5B | $4.0B | $4.3B | $5.1B |
| Margins | ||||||||||
| Gross margin | 80.6% | 44.7% | 44.0% | 45.6% | 36.6% | 42.2% | 44.0% | 50.8% | 50.6% | 51.5% |
| Operating margin | 42.4% | 16.7% | 21.7% | 21.5% | 19.3% | 23.1% | 12.4% | 28.0% | 26.8% | 31.1% |
| EBITDA margin | 48.7% | 25.3% | 29.0% | 28.6% | 24.0% | 27.9% | 16.6% | 32.2% | 30.1% | 33.7% |
| Net margin | 26.6% | 18.0% | 15.4% | 15.0% | 13.7% | 15.1% | 5.9% | 20.2% | 18.7% | 23.3% |
| FCF margin | 26.3% | 15.1% | 18.0% | 24.0% | 41.2% | 15.6% | 14.9% | 27.3% | 25.4% | 35.7% |
| Returns | ||||||||||
| Return on capital | β | β | 10.8% | 9.9% | 11.5% | 12.9% | 5.8% | 16.2% | 16.3% | 22.8% |
| Return on capital employed | 85.5% | 14.0% | 12.4% | 11.2% | 13.2% | 14.9% | 8.8% | 18.2% | 17.6% | 22.0% |
| Return on equity | 64.7% | 23.4% | 13.4% | 11.4% | 14.0% | 15.2% | 6.7% | 20.4% | 18.5% | 23.4% |
| Return on assets | 43.4% | 14.0% | 8.1% | 7.2% | 8.1% | 7.9% | 3.4% | 10.5% | 10.0% | 12.9% |
| Growth | ||||||||||
| Revenue growth | 5.9% | 217.0% | 24.2% | β9.9% | 37.3% | 2.0% | 13.3% | β4.7% | 8.5% | 15.1% |
| Net income growth | β8.9% | 115.0% | 6.2% | β12.1% | 24.9% | 13.0% | β55.6% | 224.0% | 0.5% | 43.8% |
| EPS growth | β7.7% | 62.6% | 1.9% | β11.2% | 27.8% | 15.2% | β55.5% | 225.6% | 1.1% | 44.5% |
| FCF growth | β10.1% | 81.9% | 47.9% | 19.9% | 136.1% | β61.3% | 8.3% | 74.3% | 0.9% | 61.7% |
| Share count change | β2.1% | 32.1% | 4.4% | β0.4% | β2.2% | β1.9% | β0.5% | β0.5% | β0.7% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 1.9x | 1.1x | 0.8x | 1.1x | 1.0x | 1.9x | 0.7x | 0.3x | β0.5x |
| Debt / equity | β | 0.4x | 0.4x | 0.3x | 0.4x | 0.4x | 0.5x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 52.3x | 8.7x | 14.8x | 14.2x | 17.1x | 16.8x | 8.2x | 17.0x | 21.3x | 28.1x |
| Current ratio | 2.6x | 1.3x | 1.2x | 2.2x | 1.2x | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
| Quick ratio | 2.6x | 1.3x | 1.2x | 2.2x | 1.2x | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.3% | 1.7% | 1.3% | 1.4% | 1.4% | 1.5% | 1.5% | 1.2% | 1.5% | 1.5% |
| Stock comp / revenue | 2.1% | 2.4% | 1.3% | 0.9% | 0.6% | 0.8% | 0.8% | 1.1% | 1.0% | 1.1% |
| Payouts / FCF | 75.1% | 35.1% | 54.4% | 51.4% | 36.8% | 50.3% | 52.5% | 29.8% | 43.7% | 20.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 4.0 | 7.0 | 6.0 | 7.0 | 6.0 | 8.0 | 7.0 | 9.0 |
| Altman Z'' | 13.4 | 2.7 | 3.3 | 4.1 | 3.0 | 3.4 | 2.6 | 3.8 | 4.3 | 5.1 |
| Accruals ratio | β9.9% | 1.0% | β2.0% | β4.9% | β17.0% | β1.0% | β6.0% | β4.3% | β4.4% | β7.6% |
Source: SEC EDGAR XBRL filings (CIK 0001374310). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.